Welcome to Season 5 of the award-winning Precision Medicine Podcast
Clinical conversations about the effective use of precision medicine for cancer care.
Contact us to learn about sponsorship opportunities.
Season 5
EPISODE 59
From Access to AI – Cancer in America with Dr. Douglas Flora
In this episode of the Precision Medicine Podcast, host Karan Cushman does some time traveling with Dr. Douglas Flora through his lifetime journey with cancer. Dr. Flora is the Medical Director of Oncology Services at St. Elizabeth Healthcare and Editor-in-Chief of AI in Precision Oncology, a peer-reviewed research journal dedicated to advancing artificial intelligence applications in clinical and precision oncology. Listen here
Airdate: 03.25.24 | Length: 36:40
Airdate: 05.10.23 | Length: 51:40
EPISODE 58
Dr. Pranil Chandra and Dr. Luis Raez: Enabling Comprehensive Genomic Profiling in Lung Cancer
Sponsored by
In this episode, hosts Karan Cushman and Clynt Taylor welcome back Dr. Luis Raez, Medical Director and Chief Scientific Officer at Memorial Cancer Institute who is joined by Dr. Pranil Chandra, Chief Genomic Officer of Genomic and Molecular Pathology at PathGroup. Together, we discuss the key barriers to performing comprehensive genomic profiling in lung cancer; how collaboration between oncologists and pathologists can enable a more consistent approach; and the improvements that should be made to close the gaps between the available life-extending, targeted therapies on the market today and the lung cancer patients who need them. Listen here
EPISODE 57
Dr. Debra Patt: Texas Oncology Has an “Easy Button” for Delivering Consistent Precision Oncology Care
To mark the beginning of Season 5, we are honored to welcome Dr. Debra Patt, Executive Vice President of Texas Oncology. As an breast cancer specialist at one of the nation’s largest community cancer practices, Dr. Patt is on the frontlines of oncology care every day. She joins us to discuss how Texas Oncology uses clinical decision-support technologies and health economics and health services research to deliver more consistent precision oncology care to patients at over 200 locations across Texas. Listen here
Airdate: 12.12.22 | Length: 27:40
Season 4
EPISODE 56
Do We Have the Will to Address Inequality in Precision Oncology? A conversation with Dr. Karen Winkfield
In this episode, we are joined by Dr. Karen Winkfield, Executive Director of the Meharry-Vanderbilt Alliance, appointee to President Joe Biden's National Cancer Advisory Board, and co-host of the weekly podcast, 3 Black Docs, which is dedicated to educating the community about health and health disparities in an approachable and entertaining way. Listen here
Airdate: 06.03.22 | Length: 52:40
EPISODE 55
Dr. Stephen Kingsmore on Scaling Whole-Genome Sequencing for Uncovering Genetic Defects in Infants
In episode 55 of the Precision Medicine Podcast, we welcome Dr. Stephen Kingsmore, President and CEO of the Rady Children's Institute for Genomic Medicine. Dr. Kingsmore joins us to discuss the extraordinary role whole-genome sequencing is playing in prolonging and improving the life of critically ill newborns. Listen here
Airdate: 03.29.22 | Length: 38:19
EPISODE 54
Leading Thoracic Oncologist, Dr. Christian Rolfo, Explains How Liquid Biopsies Are Advancing Precision Medicine
Dr. Christian Rolfo, President of the International Society of Liquid Biopsy and Associate Director for Clinical Research at the Center of Thoracic Oncology at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City, joins us to explain the unique role liquid biopsies are playing in the diagnosis and treatment of cancer. Listen here
Airdate: 02.16.22 | Length: 30:52
Airdate: 01.22.22 | Length: 40:12
EPISODE 53
LUNGevity Leaders Discuss Their Commitment to Educating Lung Cancer Patients About the Importance of Biomarker Testing
In this Precision Medicine Podcast episode, we are joined by Dr. Belinda King-Kallimanis, Director of Patient-Focused Research at LUNGevity—an organization that brings together research, education and support services for patients and caregivers in the lung cancer community—and Nichelle Stigger, LUNGevity board member and lung cancer survivor. They sat down with us to discuss everything from the importance of patient-friendly language in lung cancer to discrepancies in access to biomarker testing and what LUNGevity is doing to improve the status quo. Listen here
Airdate: 11.19.21 | Length: 34:52
EPISODE 52
Then and Now: The Progress of Precision Medicine Diagnostics with Hannah Mamuszka and Lena Chaihorsky of Alva10
In celebration of the three-year anniversary of the Precision Medicine Podcast, we take a look back at how far precision diagnostics have come with the help of one of our first guests Hannah Mamuszka (episode 3), Founder and CEO of Alva10, and her colleague Lena Chaihorsky. Both women are focused on resolving the knowledge gap between payers and diagnostic companies and moving diagnostics to the forefront of the precision medicine conversation. Listen here
How can we resolve the complexities of using precision medicine for cancer care?
Trapelo knows.
